Association between lipid peroxidation and risk of type 2 diabetes in women

References

• Fink G. Encyclopedia of stress. 2nd ed. Amsterdam; Boston: Academic Press; 2007.
   Google Scholar
• Mallard AR, Hollekim-Strand SM, Ingul CB, et al. High day-to-day and diurnal variability of oxidative stress and inflammation biomarkers in people with type 2 diabetes mellitus and healthy individuals. Redox Rep. 2020;25(1):64–69.
   PubMed Web of Science ®Google Scholar
• Kadiiska MB, Gladen BC, Baird DD, et al. Biomarkers of oxidative stress study II: are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning? Free Radic Biol Med. 2005;38(6):698–710.
   PubMed Web of Science ®Google Scholar
• Il’yasova D, Spasojevic I, Wang F, et al. Urinary biomarkers of oxidative status in a clinical model of oxidative assault. Cancer Epidemiol Biomarkers Prev. 2010;19(6):1506–1510.
   PubMed Web of Science ®Google Scholar
• Meigs JB, Larson MG, Fox CS, et al. Association of oxidative stress, insulin resistance, and diabetes risk phenotypes: the framingham offspring study. Diabetes Care. 2007;30(10):2529–2535.
   PubMed Web of Science ®Google Scholar
• Wu SH, Shu XO, Chow WH, et al. Nonexercise physical activity and inflammatory and oxidative stress markers in women. J Womens Health. 2014;23(2):159–167.
   PubMed Web of Science ®Google Scholar
• Davi G, Ciabattoni G, Consoli A, et al. In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation. Circulation. 1999;99(2):224–229.
   PubMed Web of Science ®Google Scholar
• Wu SH, Shu XO, Chow WH, et al. Adiposity and fat distribution in relation to inflammation and oxidative stress in a relatively lean population of chinese women. Dis Markers. 2013;34(4):279–293.
   PubMed Web of Science ®Google Scholar
• Jiang Y, Zhao Y, Milne G, et al. Quality of dietary carbohydrate is more important than its quantity in lipid peroxidation. Am J Clin Nutr. 2022;116(1):189–196.
   PubMed Web of Science ®Google Scholar
• Il’yasova D, Spasojevic I, Base K, et al. Urinary F2-isoprostanes as a biomarker of reduced risk of type 2 diabetes. Diabetes Care. 2012;35(1):173–174.
   PubMed Web of Science ®Google Scholar
• Odegaard AO, Jacobs DR, Jr., Sanchez OA, et al. Oxidative stress, inflammation, endothelial dysfunction and incidence of type 2 diabetes. Cardiovasc Diabetol. 2016;15:51.
   PubMed Web of Science ®Google Scholar
• Maritim AC, Sanders RA, Watkins JB. 3rd. Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol. 2003;17(1):24–38.
   PubMed Web of Science ®Google Scholar
• Pratico D. Lipid peroxidation in mouse models of atherosclerosis. Trends Cardiovasc Med. 2001;11:112–116.
   PubMed Web of Science ®Google Scholar
• Milne GL, Sanchez SC, Musiek ES, et al. Quantification of F2-isoprostanes as a biomarker of oxidative stress. Nat Protoc. 2007;2(1):221–226.
   PubMed Web of Science ®Google Scholar
• Il’yasova D, Scarbrough P, Spasojevic I. Urinary biomarkers of oxidative status. Clin Chim Acta. 2012;413(19-20):1446–1453.
   PubMed Web of Science ®Google Scholar
• Dorjgochoo T, Gao YT, Chow WH, et al. Major metabolite of F2-isoprostane in urine may be a more sensitive biomarker of oxidative stress than isoprostane itself. Am J Clin Nutr. 2012;96(2):405–414.
   PubMed Web of Science ®Google Scholar
• Wu X, Cai H, Xiang YB, et al. Intra-person variation of urinary biomarkers of oxidative stress and inflammation. Cancer Epidemiol Biomarkers Prev. 2010;19(4):947–952.
   PubMed Web of Science ®Google Scholar
• Zheng W, Chow WH, Yang G, et al. The shanghai women’s health study: rationale, study design, and baseline characteristics. Am J Epidemiol. 2005;162(11):1123–1131.
   PubMed Web of Science ®Google Scholar
• Morrow JD, Hill KE, Burk RF, et al. A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc Natl Acad Sci U S A. 1990;87(23):9383–9387.
   PubMed Web of Science ®Google Scholar
• Milne GL, Yin H, Brooks JD, et al. Quantification of F2-isoprostanes in biological fluids and tissues as a measure of oxidant stress. Methods Enzymol. 2007;433:113–126.
   PubMed Web of Science ®Google Scholar
• Harrell FE, Jr., Shih YC. Using full probability models to compute probabilities of actual interest to decision makers. Int J Technol Assess Health Care. 2001;17(1):17–26.
   PubMed Web of Science ®Google Scholar
• American Diabetes A. Diagnosis and classification of diabetes mellitus. Diabetes care. 2013. 36(Suppl 1): s 67–74.
   Google Scholar
• Zhang P, Li T, Wu X, et al. Oxidative stress and diabetes: antioxidative strategies. Front Med. 2020;14(5):583–600.
   PubMed Web of Science ®Google Scholar
• Davi G, Falco A, Patrono C. Lipid peroxidation in diabetes mellitus. Antioxid Redox Signal. 2005;7(1-2):256–268.
   PubMed Web of Science ®Google Scholar
• Shah S, Iqbal M, Karam J, et al. Oxidative stress, glucose metabolism, and the prevention of type 2 diabetes: pathophysiological insights. Antioxid Redox Signal. 2007;9(7):911–929.
   PubMed Web of Science ®Google Scholar
• Burgos-Moron E, Abad-Jimenez Z, Maranon AM, et al. Relationship between oxidative stress, ER stress, and inflammation in type 2 diabetes: the battle continues. J Clin Med. 2019;8:1385.
   PubMed Web of Science ®Google Scholar
• Yaribeygi H, Sathyapalan T, Atkin SL, et al. Molecular mechanisms linking oxidative stress and diabetes mellitus. Oxid Med Cell Longev. 2020;2020:8609213.
   PubMed Web of Science ®Google Scholar
• Ighodaro OM. Molecular pathways associated with oxidative stress in diabetes mellitus. Biomed Pharmacother. 2018;108:656–662.
   PubMed Web of Science ®Google Scholar
• Basu S. F2-isoprostanes in human health and diseases: from molecular mechanisms to clinical implications. Antioxid Redox Signal. 2008;10(8):1405–1434.
   PubMed Web of Science ®Google Scholar
• Hoogeveen RC, Ballantyne CM, Bang H, et al. Circulating oxidised low-density lipoprotein and intercellular adhesion molecule-1 and risk of type 2 diabetes mellitus: the atherosclerosis risk in communities study. Diabetologia. 2007;50(1):36–42.
   PubMed Web of Science ®Google Scholar
• Basu S, Helmersson J. Factors regulating isoprostane formation in vivo. Antioxid Redox Signal. 2005;7(1-2):221–235.
   PubMed Web of Science ®Google Scholar
• Stamler J, Daviglus ML, Garside DB, et al. Relationship of baseline serum cholesterol levels in 3 large cohorts of younger men to long-term coronary, cardiovascular, and all-cause mortality and to longevity. JAMA. 2000;284(3):311–318.
   PubMed Web of Science ®Google Scholar
• Klag MJ, Ford DE, Mead LA, et al. Serum cholesterol in young men and subsequent cardiovascular disease. N Engl J Med. 1993;328(5):313–318.
   PubMed Web of Science ®Google Scholar